LYKALABS.BO

Lyka Labs Limited LYKALABS.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LYKALABS.BO TAKE.NS SMSLIFE.NS SMSLIFE.BO TAKE.BO BAFNAPH.NS TLL.BO ZIMLAB.BO ZIMLAB.NS NECLIFE.BO
6M -31.57 % 326.20 % -4.45 % 0.75 % 323.70 % 41.63 % 13.61 % -34.17 % -34.17 % -12.05 %
YTD 0.82 % 3.22 % -4.35 % -0.28 % 3.32 % -14.37 % -3.84 % 12.61 % 13.03 % -25.50 %
1Y -50.91 % 169.34 % 2.28 % 3.89 % 172.22 % 57.81 % 17.98 % -24.89 % -24.82 % -61.93 %
3Y -45.95 % 81.44 % 96.69 % 110.57 % 83.08 % 27.07 % 54.18 % -10.04 % -10.93 % -30.21 %
5Y 165.08 % -29.36 % 113.95 % 128.99 % -29.41 % -8.71 % 54.18 % 163.32 % -29.07 % -30.05 %
10Y -8.69 % -69.47 % 829.18 % 889.99 % -69.61 % 267.25 % 54.18 % 127.41 % -29.07 % -57.93 %
From the beginning 258.53 % -54.24 % 829.18 % 889.99 % -55.05 % 170.07 % 54.18 % 127.41 % -29.07 % -41.07 %

Dividend

TAKE Solutions Limited

SMS Lifesciences India Limited

SMS Lifesciences India Limited

TAKE Solutions Limited

Bafna Pharmaceuticals Limited

ZIM Laboratories Limited

ZIM Laboratories Limited

Nectar Lifesciences Limited